Do Men and Women Present the Same Evolution after Left Atrial Appendage Closure?

Atrial fibrillation is a very frequent type of arrythmia that affects both men and women alike. This entity is associated to higher mortality seeing as it favors stroke and hospitalization for cardiac failure. 

El cierre de orejuela es seguro con los nuevos dispositivos

At present, one of its valid treatment strategies is left atrial appendage closure, to reduce or prevent stroke and anticoagulation driven bleeding. 

Sex differences in its outcomes and evolution have not yet been looked at. 

This was a meta-analysis of 6 studies including 64,035 patients. 26,120 were women (40.8%) and  37,915 were men.

Compared against men, women had more paroxysmal atrial fibrillation (57.7% vs. 48.2%, p < 0.001) and less diabetes (33.5% vs. 38.7%, p < 0.001), coronary artery disease (35.0% vs. 55.6%, p < 0.001), cardiac failure (33.1% vs. 37.8%, p < 0.001) and kidney failure (13.3% vs. 16.9%, p < 0.001).

The Watchman was used in 4 of the 6 studies, the Amplatzer in one another, and the remaining study used Watchman, Amplatzer, Lariat, Lambre, and Occlutech.

Read also: Drug Coated Balloons in Femoropopliteal Territory: Predictors of Failed Patency.

There were no differences in procedural success (odds ratio [OR]: 0.98, 95% confidence interval [CI]: 0.89–1.09, p = 0.77), but women presented 78% more pericardial complications (OR: 1.78, 95% CI: 1.58–2.01, p < 0.00001), twice as high bleeding rate (OR: 2.04, 95% CI:1.75–2.39, p < 0.00001) and 1.7 times more vascular complications OR: 1.75, 95% CI: 1.41–2.17,p < 0.00001).  

At 2-year followup, there were no differences in mortality or stroke. 

Conclusion

Despite having the same procedural success, women have significantly higher incidence of pericardial complications, major bleeding and vascular complications with left atrial appendage closure. Long term followup showed no difference in mortality or stroke between men and women. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Sex differences on outcomes following left atrial appendage occlusion in atrial fibrillation: A systematic review and meta‐analysis

Reference: Yuansong Zhu, et al.  Catheter Cardiovasc Interv. 2022;100:612–619.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Coronary Artery Disease in Aortic Stenosis: CABG + SAVR vs. TAVR + PCI: Data from Spanish Centers

Multiple randomized studies have shown comparable or superior efficacy of transcatheter aortic valve replacement (TAVR) vs. coronary artery bypass graft (CABG).  However, many of...

TCT 2024 | TRISCEND II: A New Hope in Percutaneous Tricuspid Valve Replacement

Advanced tricuspid regurgitation (TR) is a debilitating disease associated with heart failure and increased mortality.  Edge-to-edge repair has been shown to improve both clinical condition...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....